Context Therapeutics Inc.
CNTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $76,938 | $83,517 | $89,352 | $94,430 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,921 | $3,431 | $3,379 | $3,466 |
| Total Curr. Assets | $78,859 | $86,948 | $92,731 | $97,896 |
| Property Plant & Equip (Net) | $172 | $204 | $235 | $231 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $200 | $0 | $0 | $0 |
| Total NC Assets | $372 | $204 | $235 | $231 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $79,231 | $87,152 | $92,965 | $98,127 |
| Liabilities | – | – | – | – |
| Payables | $2,721 | $2,396 | $1,001 | $1,452 |
| Short-Term Debt | $119 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,104 | $902 | $315 | $942 |
| Total Curr. Liab. | $6,036 | $4,555 | $1,900 | $2,748 |
| LT Debt | $0 | $0 | $83 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $21 | $52 | $83 | $112 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $167 | $194 | $219 |
| Total Liabilities | $6,057 | $4,608 | $1,983 | $2,860 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $92 | $90 | $90 | $90 |
| Retained Earnings | -$117,878 | -$108,184 | -$99,357 | -$94,780 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $190,250 | $0 |
| Total Equity | $73,174 | $82,544 | $90,983 | $95,266 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $79,231 | $87,152 | $92,965 | $98,127 |
| Net Debt | -$76,819 | -$83,517 | -$89,270 | -$94,430 |